NEGR1 and depressive symptom measurement: Transcriptome and protein analysis suggest increased expression of NEGR1 in depression patients; an increased level of NEGR1 has been reported in the brain, namely in the dorsolateral prefrontal cortex (DLPFC) and in the hypothalamic area [5] of patients with major depressive disorder (MDD) in comparison with healthy controls.